Patents
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
03/2010
03/11/2010US20100062975 Method for the treatment and prevention of ocular disorders
03/11/2010US20100062537 Polypeptide Markers for the Diagnosis and Evaluation of Pelvi-Ureteric Junction Obstruction (PUJO)
03/11/2010US20100062052 Peptide-based compounds as new inhibitors of metalloectopeptidases, compositions comprising said compounds and their pharmaceutical and cosmetic uses
03/11/2010US20100062038 Markers, Antibodies and Recombinant scFvs for Mesenchymal Stem Cell Sub-populations and Osteoclasts
03/11/2010US20100062010 Novel peptide compound
03/11/2010US20100061991 Identification of therapeutic agents for HIV infection
03/11/2010US20100061932 Peptides useful as cell-penetrating peptides
03/11/2010US20100061929 Neoplasia targeting peptides and methods of using the same
03/11/2010DE102008046610A1 Verwendung einer pharmazeutischen Zusammensetzung zur lokalen Infektionstherapie sowie Medizinprodukt Use of a pharmaceutical composition for local infection therapy and medical device
03/11/2010CA2733943A1 Peptides presenting an epitope of an a domain of factor h binding protein and methods of use
03/10/2010EP2161279A1 Synthetic peptides corresponding to overlapping neutralizing determinants in the CBD1 epitope induce broadly neutralizing antibodies
03/10/2010EP2161037A2 Camptothecin-Somatostatin conjugates
03/10/2010EP2160404A1 Azapeptides as cd36 binding compounds
03/10/2010EP2160400A1 Peptides as antimicrobial agents towards campylobacter spp
03/10/2010EP2160221A1 Cyclic peptide cxcr4 antagonists
03/10/2010CN101665531A Lepista sordida protein LsAPII as well as preparation method and application thereof
03/10/2010CN101665530A Antiphytoviral black pleurotus ostreatus protein as well as preparation method and application thereof
03/10/2010CN101665529A Method for promoting solid phase synthesis of balsam pear MC-JJ22 polypeptide analogue by microwaves and application thereof
03/10/2010CN101665528A Method for promoting solid phase synthesis of balsam pear MC-JJ2 polypeptide analogue by microwaves and application thereof
03/09/2010US7674773 Glycosylated derivative of hypolipemic agents; side effect reduction; therapy for insulin resistance; hyperlipidemia agent; impaired lipid metabolism; lowering cholesterol levels
03/09/2010US7674772 Compositions and methods for treating atherosclerosis
03/09/2010US7674771 laminin binding site
03/09/2010US7674768 Processes for preparing eptifibatide
03/09/2010CA2342960C G protein-coupled receptor antagonists
03/04/2010WO2010024927A2 Treatment of amyloidoses using myelin basic protein and fragments thereof
03/04/2010WO2010024269A1 Dwarf transgenic plant, and gene for induction of dwarfing
03/04/2010WO2010024262A1 Transfection agent
03/04/2010WO2010024108A1 Prophylactic or therapeutic agent for influenza virus infection
03/04/2010WO2010023838A1 Tbc1d7 as tumor marker and therapeutic target for cancer
03/04/2010WO2010023346A1 Hybrid tripyrrole-octaarginine compounds and their use as medicament in the treatment of cancer and microbial illnesses
03/04/2010WO2010023247A1 Synthetic peptides corresponding to overlapping neutralizing determinants in the cbd1 epitope induce broadly neutralizing antibodies.
03/04/2010WO2010005515A3 Expression methods for guanylate cyclase c receptor binding polypeptides
03/04/2010WO2009149094A3 Cytotoxic t cell defined egfr peptide and an optimized derivative peptide
03/04/2010WO2009148230A3 Immunogenic peptide and composition containing the peptide for preventing or treating hpv-related diseases
03/04/2010WO2009148229A3 Immunogenic peptide and composition containing the peptide for preventing or treating hpv-related diseases
03/04/2010WO2009003284A8 Novel peptides, use thereof in cosmetic and cosmeceutic applications, and compositions comprising same
03/04/2010US20100056755 Process for Making Bivalirudin
03/04/2010US20100056612 Molecular entities for binding, stabilization and cellular delivery of charged molecules
03/04/2010US20100056459 Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway
03/04/2010US20100056458 Peptides Inhibiting Angiotensin-Converting Enzyme
03/04/2010US20100056457 Zinc Finger Binding Domains for CNN
03/04/2010US20100056456 Omega Conotoxins
03/04/2010US20100056446 NA+K+-ATPase-Specific Peptide Inhibitors/Activators of SRC and SRC Family Kinases
03/04/2010US20100056433 Novel Peptides for Use in the Treatment of Obesity
03/04/2010US20100056432 Template-fixed peptidomimetics with antibacterial activity
03/04/2010US20100055146 Cyclic angiotensin analogs
03/04/2010US20100055121 Brachyury polypeptides and methods for use
03/04/2010US20100055119 Peptides sequences and compositions
03/04/2010US20100055118 Peptidic Growth Hormone Secretagogues Analog Compounds and Preparations Thereof
03/04/2010US20100055117 Allorestricted peptide-specific t cells
03/04/2010CA2735182A1 Tbc1d7 as tumor marker and therapeutic target for cancer
03/04/2010CA2732215A1 Synthetic peptides corresponding to overlapping neutralizing determinants in the cbd1 epitope induce broadly neutralizing antibodies
03/03/2010EP2159229A1 High purity lipopeptides, lipopeptide micelles and processes for preparing same
03/03/2010EP2157967A2 Suspension formulations of insulinotropic peptides and uses thereof
03/03/2010CN101659694A Anti-tumor cyclic pentapeptide compound and preparation method thereof
03/03/2010CN101659693A Method for preparing pneumocandin B0
03/03/2010CN101659692A Method for preparing echinocandin B
03/02/2010US7671258 Surfactant peptide nanostructures, and uses thereof
03/02/2010US7671176 host cells that contain an isolated nucleic acid molecule that encodes a polypeptide having mu3 opiate receptor activity; for identifying mu3 opiate receptor agonists and antagonists
03/02/2010US7671175 animal feed additive; detergent; defensins; exhibit reduced hemolytic activity, cytotoxicity and sensitivity towards cations, such as Ca2+, Mg2+, Na+.
03/02/2010US7671028 Peptides that antagonize FPR class receptor mediated signaling
03/02/2010US7671021 Peptides that home to tumor lymphatic vasculature and methods of using same
03/02/2010US7671011 peptide comprises at least two positively charged amino acid residues; the peptide after conjugation to the fatty acid possessing antibacterial, antifungal, and/or anticancer activity higher than prior to conjugation; suitable for treatment of infections caused by pathogenic organisms such as bacteria
03/02/2010US7670852 very early marker of fertilization and embryo viability; binds to anti-CD2 antibody; Infertility
03/02/2010US7670851 Assays for preimplantation factor and preimplantation factor peptides
03/02/2010US7670850 Assays for preimplantation factor and preimplantation factor peptides
03/02/2010CA2390659C Ny-eso-1 peptide derivatives, and uses thereof
02/2010
02/25/2010WO2010021961A2 Improved production of proteins with downstream box fusions in plastids and in bacteria
02/25/2010WO2010021849A2 Recombinant fragments and synthetic peptides of 17-kda polypeptide useful in detecting bartonella henselae
02/25/2010WO2009135118A3 Lyme disease vaccine
02/25/2010US20100048865 Microwave-assisted peptide synthesis
02/25/2010US20100048862 Ferroportin1 nucleic acids, proteins, antibodies and methods
02/25/2010US20100048488 Immunomodulatory peptides
02/25/2010US20100048487 Novel cell penetrating peptide
02/25/2010US20100048482 Compositions and methods for modulating epsilon protein kinase c-mediated cytoprotection
02/25/2010US20100048469 Antimicrobial peptides
02/25/2010US20100048466 Compositions, Reagents and Kits for and Methods of Diagnosing, Monitoring and Treating Hormonal Imbalance
02/25/2010US20100048464 Bioactive peptides identified in enzymatic hydrolyzates of milk caseins and method of obtaining same
02/25/2010US20100048463 Template-fixed peptidomimetics
02/25/2010US20100048462 Truncated pth peptides with a cyclic conformation
02/25/2010US20100048459 Lantibiotic biosynthetic gene clusters from a. garbadinensis and a. liguriae
02/25/2010US20100047895 Methods for purification of bacterial cells and cell components
02/25/2010US20100047770 Detection of Breast Cancer
02/25/2010US20100047275 Peptide sequences and compositions
02/25/2010US20100047273 Coxsackie B virus and type 1 diabetes
02/25/2010US20100047170 Peptide Prodrugs
02/25/2010CA2734515A1 Inhbb epitope peptides and vaccines containing the same
02/24/2010EP2157098A2 Peptides with capacity for binding with interleukine 10 (il - 10)
02/24/2010EP2157097A1 Specific binding agents of human angiopoietin-2
02/24/2010EP2155872A1 Tem8 peptides and vaccines comprising the same
02/24/2010EP2155226A2 Compounds for inhibiting protein aggregation, and methods for making and using them
02/24/2010EP1572066B1 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2
02/24/2010EP1471936B1 Hiv vaccine and method of use
02/24/2010CN101657465A Peptides, compositions and uses thereof
02/24/2010CN101654476A Peptide-based body surface reagents for personal care
02/24/2010CN101654475A Antigenic epitope of human tumor necrosis factor alpha and preparation method and application thereof
02/24/2010CN101654474A Crohn's disease antibody epitope peptide and reagent for testing crohn's disease
02/24/2010CN100591691C Anti-tumour compound
02/23/2010US7666985 HLA-A24-restricted cancer antigen peptides
02/23/2010US7666984 Consisting of the amino acid sequence ALFDGDPHL, the peptide having the ability to bind to a molecule of human major histocompatibility complex class-I; use in immunotherapy of tumor-associated diseases and/or adenomatous diseases